Juva Life Inc. (OTCQB: JUVAF) (CSE:JUVA) (FRANKFURT:4VV), a life science company with pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, launched a new product line, Flōs, a brande
Opening a small or medium-sized cannabis business requires capital. While federal legalization of marijuana is inching closer to reality, banks are finding it difficult to keep up with regulations within different states that are constantly changing.
Cannabis-focused pharmaceutical research and development and consumer-facing company Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) has closed a dilutive financing of $11.8 million, enabling it to acquire its Stockton, California, facility as well as further its clinical research on its two novel compounds.
Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) launched the company’s first in-house branded product, a concentrate line called “Secret Sauce,” as part of a strategic effort to diversify wholesale lines into branded products.
Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) announced the completion of the final phase of construction at its 30,000-square-foot cannabis cultivation facility in Stockton, California.
Juva Life Inc. (OTCQB: JUVAF) (CSE:JUVA) (FRANKFURT:4VV) completed the final phase of construction at its 30,000-square-foot cannabis cultivation facility in Stockton, California.
Juva Life Inc. (CSE:JUVA) (OTCQB: JUVAF) (FRANKFURT:4VV) launched the Journal App, designed to help cannabis users and patients track their consumption, and gain insight into how cannabis products affect their health and wellness.